Related Experiment Videos
[Anti-aggressive effect of beta-blockers]
L'Encephale
|May 1, 1993
Summary
Beta blockers, particularly propranolol, show efficacy in treating aggressive behavior, especially in patients with organic brain syndromes. Further research is needed to clarify their use in other diagnoses and the effectiveness of alternative beta blockers.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Context:
- Aggressive behavior presents a significant clinical challenge across various patient populations.
- Beta blockers have been investigated for their potential to modulate aggressive tendencies.
- Previous studies since 1977 suggest a role for these agents in managing behavioral issues.
Purpose:
- To review the existing literature on the efficacy of beta blockers, specifically propranolol, in the treatment of violent and aggressive behavior.
- To summarize reported effective dosages, treatment durations, and adjunctive therapies.
- To identify gaps in knowledge regarding their application in diverse diagnostic groups and the utility of other beta blockers.
Summary:
- Propranolol has demonstrated effectiveness in aggressive patients with organic brain syndromes.
- Reported daily doses ranged from 60 to 1,440 mg (mean 250-400 mg), often as an adjunct to neuroleptics.
- A treatment response typically required 4 to 6 weeks of sustained therapeutic doses.
Impact:
- Highlights the potential of propranolol as a treatment for specific types of aggression.
- Underscores the need for further clinical trials to establish broader applications and compare different beta blockers.
- Informs clinical practice and future research directions in psychopharmacology for behavioral disorders.